Posted by Michael Wonder on 29 Jan 2020
Monoferric (ferric derisomaltose) injection is approved by the FDA in the US for the treatment of iron deficiency anaemia
29 January 2020 - Pharmacosmos announces that the FDA has approved Monoferric in the US for the treatment of iron deficiency anaemia.
Monoferric is an intravenous iron indicated for the treatment of iron deficiency anaemia in adult patients:
- who have intolerance to oral iron or have had unsatisfactory response to oral iron.
- who have non-hemodialysis dependent chronic kidney disease
